News summarySEC EDGARNov 10, 2026, 12:00 PM
SEC 8-K filed 2026-11-10 (items 7.01)
earningsequity_marketsregulatory_actioncorporate_earnings
Item 7.01 - Regulation FD Disclosure Officers of Elevance Health, Inc. (the “Company”) expect to speak with investors and analysts this week. During these meetings, Company officers will reaffirm the Company’s shareholders’ earnings guidance for full year 2026 to be at least $22.00 per diluted share, including approximately $7.00 per diluted share of net unfavorable items. Excluding these items, the Company continues to expect adjusted shareholders’ earnings to be at least $29.00 per diluted sha